← All organizations

U3 Pharma GmbH

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Aug 1, 2008

Acquired by Daiichi Sankyo on May 21, 2008

Timeline

2000s

Jan 1, 2001
U3 Pharma GmbH— Founded
May 21, 2008
Daiichi Sankyo— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 1 (1 own, 0 via acquisition)

patritumab

Indications

Studied for

Neoplasms

Recent trials (1)

NCT00730470Lead sponsorPhase 1Aug 1, 2008

Details

Founded: Planegg, DE Jan 1, 2001
Last known activity: Aug 1, 2008